Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RD1I
|
|||
| Former ID |
DIB016126
|
|||
| Drug Name |
XOMA-3AB
|
|||
| Synonyms |
Botulism therapy, XOMA; Botulinum type A neurotoxin mAbs (botulism), XOMA; Anti-type A botulinum neurotoxin monoclonal antibodies (botulism), XOMA/NIAID
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Clostridium infection [ICD-11: 1A04; ICD-10: A04.7] | Phase 1 | [1] | |
| Company |
Xoma; national institute of allergy and infectious diseases
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Botulinum toxin A (Bact botA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01357213) Phase 1 PK Study of XOMA 3AB. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of XOMA. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.